Showing results (1811-1820 of 5,146) with videos related to

Sort By:
Pageof 515
Multiple Sclerosis and Related Disorders|August 30, 2022
Individual differences in visual evoked potential latency are associated with variance in brain tissue volume in people with multiple sclerosis: An analysis of brain function-structure correlatesThomas J Covey, Daniel Golan, Myassar Zarif, et al.
Multiple Sclerosis and Related Disorders|August 25, 2022
Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStarTakashi Yamamura, Brian Weinshenker, Michael R Yeaman, et al.
Multiple Sclerosis and Related Disorders|December 18, 2021
Human endogenous retrovirus and multiple sclerosis: A review and transcriptome findingsLuiz H Nali, Guilherme S Olival, Horácio Montenegro, et al.
Multiple Sclerosis and Related Disorders|October 22, 2021
Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosisHelene Højsgaard Chow, Jacob Talbot, Lisbet Marstrand, et al.
Multiple Sclerosis and Related Disorders|October 23, 2021
Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MSAhmed M Elkady, Zhe Wu, Ilana R Leppert, et al.
Multiple Sclerosis and Related Disorders|February 21, 2022
Managing neuropsychological impairment in multiple sclerosis - Controlled study on a standardized metacognitive intervention (MaTiMS)Jana Pöttgen, Tim Friede, Stephanie Lau, et al.
Multiple Sclerosis and Related Disorders|February 20, 2022
Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Tracy L Fabri, Julia O'Mahony, Giulia Fadda, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021Saba Naghavi, Aryan Kavosh, Iman Adibi, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Multiple sclerosis by phenotype in GermanyJohanna Engelhard, Denise M Oleske, Sarah Schmitting, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosisLivnat Brill, Ariel Rechtman, Omri Zveik, et al.
Pageof 515